Published in Postgrad Med J on February 01, 1990
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Unsuspected coronary artery disease revealed by administration of nebulised salbutamol. Br Heart J (1994) 0.75
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulization. Postgrad Med J (1991) 0.75
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Asthma mortality in Birmingham 1975-7: 53 deaths. Br Med J (1980) 5.07
Asthma mortality in New Zealand: a two year national study. N Z Med J (1985) 4.60
Asthma in New Zealand. Br Med J (Clin Res Ed) (1983) 2.63
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) (1987) 1.72
Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol (1987) 1.57
Evaluation of some non-invasive indices of cardiovascular function [proceedings]. Br J Clin Pharmacol (1979) 1.40
The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther (1986) 1.23
Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest (1980) 1.10
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol (1984) 1.06
Sympathomimetic bronchodilator drugs. Pharmacol Ther B (1976) 1.05
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. J Am Coll Cardiol (1987) 0.93
A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists. Eur J Clin Pharmacol (1989) 0.91
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Variability in antihypertensive drug therapy in general practice: results from a random national survey. N Z Med J (1989) 2.47
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
A prospective randomized trial of external fixation and plaster cast immobilization in the treatment of distal radial fractures. J Orthop Trauma (1990) 1.97
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci U S A (1998) 1.91
House dust mite allergen (Der p 1) accumulation on new synthetic and feather pillows. Clin Exp Allergy (1999) 1.89
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
House dust mite allergen in pillows. BMJ (1996) 1.83
Obesity and asthma in 11-12 year old New Zealand children in 1989 and 2000. Thorax (2005) 1.82
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr (1994) 1.63
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
The importance of housing characteristics in determining Der p 1 levels in carpets in New Zealand homes. Clin Exp Allergy (2001) 1.61
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
Hip fracture incidence in New Zealand, revisited. N Z Med J (2001) 1.53
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Killing the canary: the international epidemiology of the homicide of media workers. J Epidemiol Community Health (2008) 1.50
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol (2002) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48